| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $584.4M | -25.3% |
| Cost of Revenue | $272.2M | -15.4% |
| Gross Profit | $312.2M | -32.2% |
| R&D Expense | $332.2M | -1.6% |
| SG&A Expense | $145.5M | -1.0% |
| Operating Income | -$165.5M | -585.1% |
| Pre-tax Income | -$154.8M | -482.6% |
| Income Tax | $36.2M | +355.7% |
| Net Income | -$191.0M |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $281.6M | +23.8% |
| Short-term Investments | $100.6M | -52.5% |
| Accounts Receivable | $54.5M | +86.0% |
| Inventory | $105.6M | -45.6% |
| Current Assets | $602.0M | -18.4% |
| Total Assets | $1.22B | -15.3% |
| Current Liabilities | $97.9M | -40.2% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Capital Expenditures | $11.7M | -47.3% |
| Investing Cash Flow | $113.1M | -75.9% |
| Financing Cash Flow | -$45.1M | +93.7% |
| -453.4% |
| EPS (Basic) | -$5.93 | -444.0% |
| EPS (Diluted) | -$5.93 | -444.0% |
| Total Liabilities |
| $142.7M |
| -39.1% |
| Stockholders' Equity | $1.08B | -10.6% |